Study of PF-07265807 in Participants With Metastatic Solid Tumors.

PHASE1TerminatedINTERVENTIONAL
Enrollment

88

Participants

Timeline

Start Date

September 24, 2020

Primary Completion Date

November 15, 2024

Study Completion Date

November 15, 2024

Conditions
Neoplasm Metastasis
Interventions
DRUG

PF-07265807

Given 2 weeks on/1 week off

DRUG

Sasanlimab

Given SC Q3W

DRUG

Axitinib

Dosed per package label starting with 5 mg PO BID

Trial Locations (33)

27705

Duke Eye Center, Durham

27710

Duke University Medical Center, lnvestigational Chemotherapy Service, Durham

28040

Hospital Universitario Fundacion Jimenez Díaz, Madrid

28050

Hospital Universitario HM Sanchinarro, Madrid

46219

Community Health Network, Inc., Indianapolis

46227

Community Health Network, Inc., Indianapolis

46250

Community Health Network Cancer Center North, Indianapolis

Community Health Network, Inc., Indianapolis

46256

Community Health Network, Inc., Indianapolis

72703

Henry Eye Clinic, Fayetteville

Highlands Oncology Group, Fayetteville

72758

Highlands Oncology Group, Rogers

72762

Highlands Oncology Group, Springdale

77030

The University of Texas M. D. Anderson Cancer Center, Houston

80045

Rocky Mountain Lions Eye Institute (RMLEI), Aurora

University of Colorado Hospital - Anschutz Cancer Pavilion (ACP), Aurora

University of Colorado Hospital - Anschutz Inpatient Pavilion (AIP), Aurora

University of Colorado Hospital - Anschutz Outpatient Pavilion (AOP), Aurora

80131

Istituto Nazionale Tumori IRCCS Fondazione Giovanni Pascale, Napoli

92868

UCI Chao Family Comprehensive Cancer Center, Orange

94158

Clinical & Translational Science Institute, San Francisco

UCSF Helen Diller Family Comprehensive Cancer Center - Mission Hall, San Francisco

UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco

02115

Brigham & Women's Hospital, Boston

02215

Dana Farber Cancer Institute, Boston

02459

Dana-Farber Cancer Institute - Chestnut Hill, Newton

07601

Hackensack University Medical Center, Hackensack

John Theurer Cancer Center at Hackensack University Medical Center, Hackensack

M5G 2M9

University Health Network, Toronto

00168

Fondazione Policlinico Universitario Agostino Gemelli IRCCS - Università Cattolica del Sacro Cuore, Roma

Fondazione Policlinico Universitario Agostino Gemelli IRCCS - Università Cattolica del Sacro Cuore, Roma

277-8577

National Cancer Center Hospital East, Kashiwa

08035

Hospital Universitari Vall d'Hebron, Barcelona

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY